
Stephan Grupp
Co-PD for Pediatric Oncology, ACC · University of Pennsylvania Health System
Credentials: · · · ·
History
- Present
Co-PD for Pediatric Oncology, ACC · University of Pennsylvania Health System
- Present
Cellular Therapy and Transplant Section · Children's Hospital of Philadelphia
- Present
Susan P. and Stephen S. Kelly Center for Cancer Immunotherapy · University of Pennsylvania Health System
- 1990–1991
Dana Farber Cancer Institute and Children's Hospital
1987–1990
Research
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
New England Journal of Medicine · 2018 · 4,577 citations
Chimeric antigen receptor T cells for sustained remissions in leukemia
New England Journal of Medicine · 2014 · Last of 19 authors · 4,445 citations
Review · Biology of Blood and Marrow Transplantation · 2019 · 3,048 citations

60 papers · 11 as a fellow

57 papers · 3 as a fellow

54 papers

42 papers

40 papers

33 papers

29 papers

27 papers · 5 as a fellow
Grants
- 2026–2031
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $890K · Children's Hosp of Philadelphia
- 1997–2027
Abramson Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1M · University of Pennsylvania
- 2019–2024
Defining and Overcoming Intrinsic T Cell Dysfunction to Enable Pediatric Immunotherapy
National Cancer Institute · U01
Contact PI · $3.7M · Children's Hosp of Philadelphia
- 2020–2024
The Cell and Gene Therapy Toolkit for Junior Faculty
National Cancer Institute · UE5
PI · $997.2K · University of Pennsylvania
Clinical trials
- 2016–2021
Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome
Principal investigator · Completed · Phase 1
University of Pennsylvania
- 2016–2037
CD22 Redirected Autologous T Cells for ALL
Principal investigator · Active not recruiting · Phase 1
University of Pennsylvania
- 2011–2019
Principal investigator · Completed · Phase 1, Phase 2
University of Pennsylvania
- 2010–2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Principal investigator · Completed · Phase 3
Children's Oncology Group



